Vicore Pharma Holding AB Sponsored ADR share price logo

Vicore Pharma Holding AB Sponsored ADR

NASDAQ: VCRE

Small Cap

$9.91

+0.01

(+0.10%)

as on

Vicore Pharma Holding AB Sponsored ADR Stock Performance

as on November 20, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $9.90
    $10.27
    downward going graph

    0.10%

    Downside

    3.63%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Vicore Pharma Holding AB Sponsored ADR share price movements today

Previous Close
$9.90
Open
$10.15
Volume
720.0K
Market Cap
$278.8M
Day's Low - High
$9.90 - $10.27

Vicore Pharma Holding AB Sponsored ADR Historical Returns

1 Month Return
+ 10.11 %
3 Month Return
-17.42 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Vicore Pharma Holding AB Sponsored ADR Stock Fundamentals & Key Indicators

Check Vicore Pharma Holding AB Sponsored ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$278.8M

EPS (TTM)

-5.92

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.47

Industry PE ratio

0.00

PEG Ratio

-0.35

EBITDA

-367.6M

Revenue (TTM)

1.8M

Profit Margin

100.00%

Return On Equity TTM

-55.97%

Vicore Pharma Holding AB Sponsored ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vicore Pharma Holding AB Sponsored ADR with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$278.8MNA-5.47100.00%0.00%
Neutral$83.7B-25.40%-29.1428.00%0.00%
StrongBuy$47.2BNA65.7688.39%0.00%
StrongBuy$135.4B193.33%34.1185.53%0.00%
Buy$99.1B44.87%20.2985.77%0.39%

Analyst Recommendation on Vicore Pharma Holding AB Sponsored ADR Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Vicore Pharma Holding AB Sponsored ADR. Average target price of $25

Vicore Pharma Holding AB Sponsored ADR Share Price Target

Get share price movements and forecasts by analysts on Vicore Pharma Holding AB Sponsored ADR.

Current Price

$9.91

Analyzed by

3 Analysts

High

$35

0

Low

$15

Vicore Pharma Holding AB Sponsored ADR target price $0, a slight upside of 0% compared to current price of $9.91. According to 3 analysts rating.

Indian Investors' Interest in Vicore Pharma Holding AB Sponsored ADR Stock

Search interest for Vicore Pharma Holding AB Sponsored ADR Stock has increased by 25% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:25% versus previous 30 day period

Vicore Pharma Holding AB Sponsored ADR Quarterly Profit & Loss

All numbers in Millions USD

Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Income
-12
-133
-123
-15
-133
EBITDA
-12
-128
-107
-
-131
Interest Expense
-
8
0
0
-
Depreciation
0
-
-
15
-
Income Before Tax
-12
-137
-108
-14
-124
Income Tax Expense
-
-
0
0
-
Net Income
-12
-137
-108
-14
-124
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%

Vicore Pharma Holding AB Sponsored ADR Annual Profit & Loss

All numbers in Millions USD

Dec 2025
Total Revenue
3
Gross Profit
3
Operating Income
-454
EBITDA
-477
Interest Expense
0
Depreciation
-
Income Before Tax
-477
Income Tax Expense
-
Net Income
-477
Net Profit Margin
100.00%

Vicore Pharma Holding AB Sponsored ADR Quarterly Cash Flow

All numbers in Millions USD

Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Net Income
-12
-133
-123
-14
-124
Operating Cash Flow
-10
-81
-117
-16
-137
Investing Cash Flow
23
-237
-88
205
100
Financing Cash Flow
-
430
-
-
0
Change in Cash
12
108
-200
51
-32

Vicore Pharma Holding AB Sponsored ADR Annual Cash Flow

All numbers in Millions USD

Dec 2025
Net Income
-452
Operating Cash Flow
-375
Investing Cash Flow
-600
Financing Cash Flow
430
Change in Cash
-577

Global Institutional Holdings in Vicore Pharma Holding AB Sponsored ADR

Check out the Institutions with significant holdings in Vicore Pharma Holding AB Sponsored ADR.

Funds
Holdings
Shares Held
Franklin Strategic Series
0.46%
130759

Insights on Vicore Pharma Holding AB Sponsored ADR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, VCRE stock has moved up by 10.0%

About Vicore Pharma Holding AB Sponsored ADR

Vicore Pharma Holding AB (publ), a Gothenburg, Sweden-based company, specializes in the discovery and advancement of therapies for rare lung conditions. Its core pipeline features VP01, an orally administered small molecule currently in Phase II clinical trials for indications such as interstitial lung diseases, idiopathic pulmonary fibrosis (IPF), systemic sclerosis, and COVID-19. The company is also progressing VP02, a novel formulation and delivery approach for an established immunomodulatory compound, which is in preclinical development for treating IPF. Vicore maintains strategic alliances, including a development cooperation with Emeriti Bio AB, a licensing arrangement with Nanologica AB (publ), and a collaboration with Alex Therapeutics AB focused on creating and clinically validating a digital therapeutic (DTx) built on the Alex DTx platform. Established in 2000, the company was formerly known as Mintage Scientific AB.
OrganisationVicore Pharma Holding AB Sponsored ADR
HeadquartersKornhamnstorg 53, Stockholm, AB, 111 27, SE
IndustryBiotechnology
CEOAhmed S. Mousa

Key Management of Vicore Pharma Holding AB Sponsored ADR

Name

Title

Mr. Ahmed S. Mousa J.D.

Chief Executive Officer

Mr. Hans Jeppsson Ph.D.

Chief Financial Officer

Ms. Nina Carlen

Chief Administrative Officer

Mr. Jason Hoffman

VP & Head of Human Resources

Mr. Mikael Nygård

Chief Operating Officer

Ms. Helen Barker

Chief Technology Officer

Dr. Rob Slack Ph.D.

Chief Scientific Officer

Mr. Karam Hijji

General Counsel

Ms. Johanna Grans Ph.D.

Head of Non-Clinical Development

Mr. Jimmie Hofman

Chief Business Officer

FAQs

What is Vicore Pharma Holding AB Sponsored ADR share price today?

Vicore Pharma Holding AB Sponsored ADR share price today is $9.91 as on at the close of the market. Vicore Pharma Holding AB Sponsored ADR share today touched a day high of $10.27 and a low of $9.90.

What is the 52 week high and 52 week low for Vicore Pharma Holding AB Sponsored ADR share?

Vicore Pharma Holding AB Sponsored ADR share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Vicore Pharma Holding AB Sponsored ADR stock price today i.e. is closed at $9.91,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Vicore Pharma Holding AB Sponsored ADR's market capitalisation today?

Vicore Pharma Holding AB Sponsored ADR market capitalisation is $0.00T as on .

How to invest in Vicore Pharma Holding AB Sponsored ADR Stock (VCRE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vicore Pharma Holding AB Sponsored ADR on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Vicore Pharma Holding AB Sponsored ADR Stock (VCRE) from India?

Indian investors can start investing in Vicore Pharma Holding AB Sponsored ADR (VCRE) shares with as little as ₹93.29000091552734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹932.90 in Vicore Pharma Holding AB Sponsored ADR stock (as per the Rupee-Dollar exchange rate as on ). Based on Vicore Pharma Holding AB Sponsored ADR share’s latest price of $9.91 as on November 20, 2026 at 2:29 am IST, you will get 1.0091 shares of Vicore Pharma Holding AB Sponsored ADR. Learn more about fractional shares .